PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Usher Institute, University of Edinburgh, Edinburgh, UK. Monica.Fletcher@ed.ac.uk.\', \'Department of General Practice and GRIAG Research Institute, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.\', \'Department of Pharmacy and Bioengineering, University of Keele, Keele, Staffordshire, UK.\', \'Respiratory, GlaxoSmithKline, Brentford, London, UK.\', \'Respiratory, General Medicines Emerging Markets, GlaxoSmithKline, Singapore, 139234, Singapore.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s12325-022-02056-x
?:doi
?:hasPublicationType
?:journal
  • Advances in therapy
is ?:pmid of
?:pmid
?:pmid
  • 35157217
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.075
?:rankingScore_hIndex
  • 51
is ?:relation_isRelatedTo_publication of
?:title
  • Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35157217>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35157217>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all